Manulife (Manufacturers Life Insurance)
IDYA icon

Manulife (Manufacturers Life Insurance)’s IDEAYA Biosciences IDYA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01M Buy
107,585
+34,679
+48% +$1.06M ﹤0.01% 1292
2026
Q1 		$2.43M Buy
72,906
+2,997
+4% +$101K ﹤0.01% 1422
2025
Q4 		$2.41M Buy
69,909
+3,416
+5% +$109K ﹤0.01% 1447
2025
Q3 		$1.81M Sell
66,493
-4,691
-7% -$113K ﹤0.01% 1560
2025
Q2 		$1.5M Sell
71,184
-1,126
-2% -$21.6K ﹤0.01% 1627
2025
Q1 		$1.18M Sell
72,310
-10,292
-12% -$219K ﹤0.01% 1737
2024
Q4 		$2.12M Sell
82,602
-15,785
-16% -$447K ﹤0.01% 1533
2024
Q3 		$3.12M Sell
98,387
-6,397
-6% -$243K ﹤0.01% 1395
2024
Q2 		$3.68M Sell
104,784
-7,137
-6% -$283K ﹤0.01% 1295
2024
Q1 		$4.91M Buy
111,921
+19,483
+21% +$838K ﹤0.01% 1200
2023
Q4 		$3.29M Buy
92,438
+14,028
+18% +$419K ﹤0.01% 1317
2023
Q3 		$2.12M Buy
78,410
+32,192
+70% +$816K ﹤0.01% 1417
2023
Q2 		$1.09M Buy
46,218
+29,374
+174% +$604K ﹤0.01% 1610
2023
Q1 		$231K Sell
16,844
-29,866
-64% -$498K ﹤0.01% 2462
2022
Q4 		$848K Buy
46,710
+2,531
+6% +$42.6K ﹤0.01% 1694
2022
Q3 		$635K Sell
44,179
-370
-0.8% -$4.81K ﹤0.01% 1827
2022
Q2 		$617K Sell
44,549
-15,421
-26% -$172K ﹤0.01% 1901
2022
Q1 		$671K Buy
59,970
+42,702
+247% +$629K ﹤0.01% 1996
2021
Q4 		$407 Buy
17,268
+154
+0.9% +$3.58K ﹤0.01% 2404
2021
Q3 		$436K Buy
17,114
+681
+4% +$15.9K ﹤0.01% 2398
2021
Q2 		$345K Buy
16,433
+5,662
+53% +$116K ﹤0.01% 2709
2021
Q1 		$253K Buy
10,771
+144
+1% +$2.78K ﹤0.01% 2731
2020
Q4 		$149K Buy
+10,627
New +$144K ﹤0.01% 2866

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s IDYA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its IDEAYA Biosciences (IDYA) stake by 48% in Q2 2026, buying an estimated $1.06M and bringing the position to 107,585 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Manulife (Manufacturers Life Insurance) first reported a position in IDYA in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.91M in Q1 2024. 282 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 107,585 shares of IDEAYA Biosciences worth $4.01M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 34,679 IDEAYA Biosciences shares in Q2 2026, an estimated $1.06M.
  • IDEAYA Biosciences made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1292 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 23 quarters since.
  • Manulife (Manufacturers Life Insurance)'s IDEAYA Biosciences position peaked at $4.91M in Q1 2024.
  • 282 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.